Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

LEXXEL

ENALAPRIL MALEATE; FELODIPINE

Standard Dose
5MG;5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview LEXXEL is listed in Drugs@FDA under application 020668 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ENALAPRIL MALEATE; FELODIPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 5MG;5MG Sponsor ASTRAZENECA Submission history Latest submission status date: 2007-10-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview LEXXEL is listed in Drugs@FDA under application 020668 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ENALAPRIL MALEATE; FELODIPINE Form and strength TABLET, EXTENDED RELEASE;ORAL - 5MG;5MG Sponsor ASTRAZENECA Submission history Latest submission status date: 2007-10-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.